Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 6/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1897757 | 0.92 | ALDH1A1 (0.40) | TACR3TAS1R3TAS1R1ALDH1A1CNR2 | |
| SCHEMBL31373087 | 0.92 | ALDH1A1 (0.40) | TACR3TAS1R3TAS1R1ALDH1A1CNR2 | |
| SCHEMBL8883577 | 0.80 | TAS1R3 (0.36) | TACR3KDM4EKMT2AL3MBTL1TAS1R3 | |
| SCHEMBL8883095 | 0.79 | TAS1R3 (0.35) | TACR3KMT2ATAS1R3TAS1R1CNR2 | |
| SCHEMBL3623844 | 0.78 | TACR3 (0.37) | TACR3KDM4EKMT2AL3MBTL1TAS1R3 | |
| SCHEMBL16538080 | 0.77 | NAAA (0.53) | KDM4EL3MBTL1ALDH1A1CNR2CNR1 | |
| SCHEMBL8883099 | 0.77 | TAS1R3 (0.39) | TACR3KDM4EKMT2AL3MBTL1TAS1R3 | |
| SCHEMBL18694713 | 0.76 | TAS1R3 (0.47) | KDM4EKMT2AL3MBTL1TAS1R3TAS1R1 | |
| SCHEMBL8975448 | 0.76 | TAS1R3 (0.37) | TACR3KMT2ATAS1R3TAS1R1ALOX5 | |
| SCHEMBL16538078 | 0.76 | ALOX5 (0.53) | KDM4EL3MBTL1ALDH1A1CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090056793-A1 | BENZOTERRYLENE DERIVATIVES | SABIC INNOVATIVE PLASTICS IP BV (NL) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090056793-A1 | BENZOTERRYLENE DERIVATIVES | NR2E3, NR1H3, NR1H2 | TACR3 1081/4885KDM4E 1340/4885KMT2A 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.